Amyloid-β, Anxiety, and Cognitive Decline in Preclinical Alzheimer Disease: A Multicenter, Prospective Cohort Study

The validity of the Hospital Anxiety and Depression Scale

Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · see citing works

Anxiety and cognitive performance: Attentional control theory

Eysenck, M. W., Derakshan, N., Santos, R., & Calvo, M. G. (2007) · Emotion · doi:10.1037/1528-3542.7.2.336 · Cited by 5,289 · see citing works

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279 · see citing works

Brain on stress: how the social environment gets under the skin

McEwen, B. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121254109 · Cited by 1,200 · see citing works

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Clark, C. M. (2011) · JAMA · doi:10.1001/jama.2010.2008 · Cited by 1,117 · see citing works

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · see citing works

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 970 · see citing works

Antidepressants increase neural progenitor cells in the human hippocampus

Boldrini, M., Underwood, M. D., Hen, R., Rosoklija, G. B., Dwork, A. J., John Mann, J., & Arango, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.75 · Cited by 686 · see citing works

18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

Vandenberghe, R. R., Laere, K. V., Ivanoiu, A., Salmon, É., Bastin, C., Triau, E., Hasselbalch, S. G., Law, I. G., Andersen, A., Kørner, A., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22068 · Cited by 649 · see citing works

Assessment of Memory Complaint in Age-Associated Memory Impairment: The MAC-Q

Crook, T. H., Feher, E. P., & Larrabee, G. J. (1992) · International Psychogeriatrics · doi:10.1017/s1041610292000991 · Cited by 434 · see citing works

Preventing the onset of major depressive disorder: A meta-analytic review of psychological interventions

van Zoonen, K., Buntrock, C., Ebert, D. D., Smit, F., Reynolds, C. F., Beekman, A. T., & Cuijpers, P. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt175 · Cited by 425 · see citing works

Hippocampal Angiogenesis and Progenitor Cell Proliferation Are Increased with Antidepressant Use in Major Depression

Boldrini, M., Hen, R., Underwood, M. D., Rosoklija, G. B., Dwork, A. J., Mann, J. J., & Arango, V. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.024 · Cited by 348 · see citing works

Baseline Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: A Population-Based Study

Geda, Y. E., Roberts, R. O., Mielke, M. M., Knopman, D. S., Christianson, T. J. H., Pankratz, V. S., Boeve, B. F., Sochor, O., Tangalos, E. G., Petersen, R. C., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13060821 · Cited by 338 · see citing works

Stepped-Care Prevention of Anxiety and Depression in Late Life

Veer-Tazelaar, P. J. V., van Marwijk, H., van Oppen, P., van Hout, H. P. J., van der Horst, H. E., Cuijpers, P. J., Smit, F., & Beekman, A. T. F. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.555 · Cited by 320 · see citing works

Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies

Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., & Iosifescu, D. V. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.06.006 · Cited by 307 · see citing works

Late-Life Anxiety and Cognitive Impairment: A Review

Beaudreau, S. A., & O'Hara, R. M. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31817945c3 · Cited by 290 · see citing works

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study

Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255 · see citing works

An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice

Sheline, Y., West, T., Yarasheski, K., Swarm, R., Jasielec, M. S., Fisher, J. R., Ficker, W. D., Yan, P., Xiong, C., Frederiksen, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008169 · Cited by 238 · see citing works

Psychological treatments for depression and anxiety in dementia and mild cognitive impairment

Orgeta, V., Qazi, A., Spector, A. E., & Orrell, M. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009125.pub2 · Cited by 208 · see citing works

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease

Lim, Y. Y., Maruff, P. T., Pietrzak, R. H., Ames, D. J., Ellis, K. A., Harrington, K., Lautenschlager, N. T., Szoeke, C. E. I., Martins, R. N., Masters, C. L., et al. (2013) · Brain · doi:10.1093/brain/awt286 · Cited by 207 · see citing works

The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults.

Beaudreau, S. A., & O'Hara, R. M. (2009) · Psychology and Aging · doi:10.1037/a0016035 · Cited by 201 · see citing works

Effects of Anxiety Versus Depression on Cognition in Later Life

Bierman, E. J. M., Comijs, H. C., Jonker, C., & Beekman, A. T. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200508000-00007 · Cited by 201 · see citing works

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195 · see citing works

Clinical Effectiveness of Individual Cognitive Behavioral Therapy for Depressed Older People in Primary Care: A Randomized Controlled Trial

Serfaty, M. A., Haworth, D., Blanchard, M., Buszewicz, M., Murad, S., & King, M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.165 · Cited by 190 · see citing works

Intraneuronal β-Amyloid Accumulation in the Amygdala Enhances Fear and Anxiety in Alzheimer's Disease Transgenic Mice

España, J., Giménez‐Llort, L., Valero, J., Miñano-Molina, A. J., Rábano, A., Rodrı́guez-Álvarez, J., LaFerla, F. M., & Saura, C. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.015 · Cited by 184 · see citing works

Late life anxiety is associated with decreased memory and executive functioning in community dwelling older adults

Yochim, B. P., Mueller, A. E., & Segal, D. L. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.10.010 · Cited by 155 · see citing works

Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease

Chételat, G., Villemagne, V. L., Pike, K. E., Ellis, K. A., Bourgeat, P., Jones, G. R., O'Keefe, G. J., Salvado, O., Szoeke, C. E. I., Martins, R. N., et al. (2011) · Brain · doi:10.1093/brain/awq383 · Cited by 153 · see citing works

Incidence of cerebral microbleeds in preclinical Alzheimer disease

Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150 · see citing works

Ushering in the study and treatment of preclinical Alzheimer disease

Langbaum, J. B. S., Fleisher, A., Chen, K., Ayutyanont, N., Lopera, F. J., Quiroz, Y. T., Caselli, R. J., Tariot, P. N., & Reiman, E. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.107 · Cited by 145 · see citing works

Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?

Mowla, A., Mosavinasab, M., & Pani, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e0002 · Cited by 141 · see citing works

Does Anxiety Affect Risk of Dementia? Findings From the Caerphilly Prospective Study

Gallacher, J., Bayer, A., Fish, M., Pickering, J., Pedro, S., Dunstan, F., Ebrahim, S., & Ben-Shlomo, Y. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181a6177c · Cited by 137 · see citing works

Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?

Mowla, A., Mosavinasab, M., Haghshenas, H., & Borhani‐Haghighi, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814b98c1 · Cited by 115 · see citing works

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment

Ramakers, I. H. G. B., Verhey, F. R. J., Scheltens, P., Hampel, H. J., Soininen, H. S., Aalten, P., Rikkert, M. G. M. O., Verbeek, M. M., Spiru, L., Blennow, K., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712001870 · Cited by 115 · see citing works

Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model

Brureau, A., Zussy, C., Delair, B., Ogier, C., IXART, G., Maurice, T., & Givalois, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.015 · Cited by 112 · see citing works

Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic Intervention

Caselli, R. J., & Reiman, E. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129026 · Cited by 109 · see citing works

Depression and Anxiety Symptoms Are Associated With Cerebral FDDNP-PET Binding in Middle-Aged and Older Nondemented Adults

Lavretsky, H., Siddarth, P., Kepe, V., Ercoli, L. M., Miller, K. J., Burggren, A. C., Bookheimer, S. Y., Huang, S., Barrio, J. R., & Small, G. W. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181953b82 · Cited by 108 · see citing works

Anxiety, Depression, and 1‐Year Incident Cognitive Impairment in Community‐Dwelling Older Adults

Potvin, O., Forget, H., Grenier, S., Préville, M., & Hudon, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03521.x · Cited by 107 · see citing works

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

Lim, Y. Y., Ellis, K. A., Pietrzak, R. H., Ames, D. J., Darby, D., Harrington, K., Martins, R. N., Masters, C. L., Rowe, C. C., Savage, G. R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e9ae6 · Cited by 107 · see citing works

The association between depression, anxiety, and cognitive function in the elderly general population—the Hordaland Health Study

Biringer, E., Mykletun, A., Dahl, A. A., Smith, A. D., Engedal, K., Nygaard, H. A., & Lund, A. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1390 · Cited by 101 · see citing works

Human anterior and posterior hippocampus respond distinctly to state and trait anxiety.

Satpute, A. B., Mumford, J. A., Naliboff, B. D., & Poldrack, R. A. (2012) · Emotion · doi:10.1037/a0026517 · Cited by 99 · see citing works

Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults

Huijbers, W., Mormino, E. C., Wigman, S. E., Ward, A. M., Vannini, P., McLaren, D. G., Becker, J. A., Schultz, A. P., Hedden, T., Johnson, K. A., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3579-13.2014 · Cited by 89 · see citing works

Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease

Lim, Y. Y., Maruff, P. T., Pietrzak, R. H., Ellis, K. A., Darby, D., Ames, D. J., Harrington, K., Martins, R. N., Masters, C. L., Szoeke, C. E. I., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.11.005 · Cited by 80 · see citing works

Anxiety symptoms and cognitive performance in later life: Results from the longitudinal aging study Amsterdam

Bierman, E. J. M., Comijs, H. C., Rijmen, F., Jonker, C., & Beekman, A. T. F. (2008) · Aging & Mental Health · doi:10.1080/13607860802224276 · Cited by 76 · see citing works

Decline in Cognitive Function over 18 Months in Healthy Older Adults with High Amyloid-β

Ellis, K. A., Lim, Y. Y., Harrington, K., Ames, D. J., Bush, A. I., Darby, D., Martins, R. N., Masters, C. L., Rowe, C. C., Savage, G. R., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122170 · Cited by 47 · see citing works

State Anxiety and Cognitive Functioning in Older Adults

Potvin, O., Bergua, V., Meillon, C., Goff, M. L., Bouisson, J., Dartigues, J., & Amieva, H. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.029 · Cited by 46 · see citing works

Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study

Pietrzak, R. H., Scott, J. C., Neumeister, A., Lim, Y. Y., Ames, D. J., Ellis, K. A., Harrington, K., Lautenschlager, N. T., Szoeke, C. E. I., Martins, R. N., et al. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134239 · Cited by 45 · see citing works

Anxiety disorders, depressive episodes and cognitive impairment no dementia in community‐dwelling older men and women

Potvin, O., Hudon, C., Dion, M., Grenier, S., & Préville, M. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2647 · Cited by 43 · see citing works

The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI

Harrington, K., Lim, Y. Y., Ellis, K. A., Copolov, C., Darby, D., Weinborn, M., Ames, D. J., Martins, R. N., Savage, G. R., Szoeke, C. E. I., et al. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001087 · Cited by 35 · see citing works

Vascular Risk Factors and Cognitive Functions in Nondemented Elderly Individuals

Wiederkehr, S., Laurin, D., Simard, M., Verreault, R., & Lindsay, J. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709335797 · Cited by 24 · see citing works

Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: the Aging, Demographics, and Memory Study (ADAMS)

Beaudreau, S. A., Fairchild, J. K., Spira, A. P., Lazzeroni, L. C., & O'Hara, R. M. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3868 · Cited by 17 · see citing works

Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: An update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study

Ellis, K., Rainey-Smith, S., Rembach, A., Macaulay, S., & Villemagne, V. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.870136 · Cited by 17 · see citing works

Subjective Cognitive Decline in Preclinical Alzheimer's Disease

Rabin, L. A., Smart, C. M., & Amariglio, R. E. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045136 · Cited by 590 · see citing works

Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model

Luo, R., Su, L.-Y., Li, G., Yang, J., Liu, Q., Yang, L.-X., Zhang, D.-F., Zhou, H., Xu, M., Fan, Y., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1596488 · Cited by 364 · see citing works

Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis

Liu, Q., Xi, Y., Wang, Q., Liu, J., Li, P., Meng, X., Liu, K., Chen, W., Liu, X., & Liu, Z. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.005 · Cited by 241 · see citing works

Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease: a systematic review of symptom-general and –specific lesion patterns

Chen, Y., Dang, M., & Zhang, Z. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00456-1 · Cited by 224 · see citing works

Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility

Mortamais, M., Ash, J. A., Harrison, J., Kaye, J. A., Kramer, J. H., RANDOLPH, C. C., Pose, C., Albala, B., Ropacki, M. T., Ritchie, C. W., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.2365 · Cited by 191 · see citing works

Subjective cognitive decline in cognitively normal elders from the community or from a memory clinic: Differential affective and imaging correlates

Perrotin, A., La Joie, R., de La Sayette, V., Barré, L., Mézenge, F., Mutlu, J., Guilloteau, D., Egret, S., Eustache, F., & Chételat, G. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.011 · Cited by 179 · see citing works

Apathy and anxiety are early markers of Alzheimer's disease.

Johansson, M., Stomrud, E., Lindberg, O., Westman, E., Johansson, P., van Westen, D., Mattsson, N., & Hansson, O. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.008 · Cited by 156 · see citing works

Anxiety and cognition

Maloney, E. A., Sattizahn, J. R., & Beilock, S. L. (2014) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1299 · Cited by 160 · see citing works

Posterior basolateral amygdala to ventral hippocampal CA1 drives approach behaviour to exert an anxiolytic effect

Pi, G., Gao, D., Wu, D., Wang, Y., Lei, H., Zeng, W., Gao, Y., Yu, H., Xiong, R., Jiang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13919-3 · Cited by 154 · see citing works

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable

Knopman, D. S., Haeberlein, S. B., Carrillo, M. C., Hendrix, J. A., Kerchner, G., Margolin, R. A., Maruff, P. T., Miller, D. S., Tong, G., Tome, M. B., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.03.002 · Cited by 140 · see citing works

The Relationship Between Anxiety and Alzheimer’s Disease

Mendez, M. F. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210294 · Cited by 142 · see citing works

High depression and anxiety in people with Alzheimer's disease living in retirement homes during the covid-19 crisis

Haj, M. E., Altıntaş, E., Chapelet, G., Kapogiannis, D., & Gallouj, K. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113294 · Cited by 138 · see citing works

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

Slot, R. E. R., Verfaillie, S. C. J., Overbeek, J. M., Timmers, T., Wesselman, L. M. P., Teunissen, C. E., Dols, A., Bouwman, F. H., Prins, N. D., Barkhof, F., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0390-y · Cited by 132 · see citing works

Support for midlife anxiety diagnosis as an independent risk factor for dementia: a systematic review

Gimson, A., Schlosser, M., Huntley, J. D., & Marchant, N. L. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019399 · Cited by 130 · see citing works

Anxiety Disorders in the Elderly

Andreescu, C., & Lee, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_28 · Cited by 122 · see citing works

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort

Simuni, T., Caspell‐Garcia, C., Coffey, C. S., Weintraub, D. A., Mollenhauer, B., Lasch, S., Tanner, C. M., Jennings, D. L., Kieburtz, K. D., Chahine, L. M., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316213 · Cited by 119 · see citing works

Chronic stress and <scp>A</scp> lzheimer's disease: the interplay between the hypothalamic–pituitary–adrenal axis, genetics and microglia

Milligan Armstrong, A., Porter, T., Quek, H., White, A., Haynes, J., Jackaman, C., Villemagne, V., Munyard, K., Laws, S. M., Verdile, G., et al. (2021) · Biological Reviews · doi:10.1111/brv.12750 · Cited by 116 · see citing works

Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease

Hoffman, J. L., Faccidomo, S., Kim, M., Taylor, S. M., Agoglia, A. E., May, A. M., Smith, E. N., Wong, L. C., & Hodge, C. W. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.017 · Cited by 109 · see citing works

Repetitive negative thinking is associated with amyloid, tau, and cognitive decline

Marchant, N. L., Lovland, L. R., Jones, R., Binette, A. P., Gonneaud, J., Arenaza‐Urquijo, E. M., Chételat, G., & Villeneuve, S. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12116 · Cited by 107 · see citing works

Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort

Matušková, V., Ismail, Z., Nikolai, T., Marková, H., Čechová, K., Nedelská, Z., Laczó, J., Wang, M., Hort, J., & Vyhnálek, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.643271 · Cited by 108 · see citing works

Redox modulation of cellular stress response and lipoxin A4 expression by Hericium Erinaceus in rat brain: relevance to Alzheimer’s disease pathogenesis

Salinaro, A. T., Siracusa, R., Paola, R. D., Scuto, M. C., Ontario, M. L., Bua, R. O., Mauro, P. D., Toscano, M. A., Petralia, C. C. T., Maiolino, L., et al. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0078-8 · Cited by 100 · see citing works

Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment

Grill, J. D., Raman, R., Ernstrom, K. B., Sultzer, D. L., Burns, J. M., Donohue, M., Johnson, K. A., Aisen, P. S. S., Sperling, R. A., Karlawish, J. H., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2734 · Cited by 98 · see citing works

Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults

Guo, T., Landau, S. M., Jagust, W. J., & Initiative, A. D. N. (2020) · Neurology · doi:10.1212/wnl.0000000000009216 · Cited by 95 · see citing works

Psychosocial risk factors and Alzheimer's disease: the associative effect of depression, sleep disturbance, and anxiety

Burke, S. L., Cadet, T. J., Alcide, A., O’Driscoll, J., & Maramaldi, P. (2017) · Aging & Mental Health · doi:10.1080/13607863.2017.1387760 · Cited by 92 · see citing works

Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression

Perna, G., Iannone, G., Alciati, A., & Caldirola, D. (2015) · Neural Plasticity · doi:10.1155/2016/8457612 · Cited by 96 · see citing works

Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer’s disease mouse models

Huang, Y., Skwarek‐Maruszewska, A., Horré, K., Vandewyer, E., Wolfs, L., Snellinx, A., Saito, T., Radaelli, E., Corthout, N., Colombelli, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3492 · Cited by 90 · see citing works

New Research on Anxiety Disorders in the Elderly and an Update on Evidence-Based Treatments

Andreescu, C., & Varon, D. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0595-8 · Cited by 85 · see citing works

A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers

Lawrence, E., Vegvari, C., Ower, A. K., Hadjichrysanthou, C., de Wolf, F., & Anderson, R. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170261 · Cited by 84 · see citing works

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia

Ettcheto, M., Olloquequi, J., Sánchez‐López, E., Busquets, O., Cano, A. C., Manzine, P. R., Beas‐Zárate, C., Castro-Torres, R. D., García, M. L., Bulló, M., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00344 · Cited by 83 · see citing works

Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 82 · see citing works

ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease

Esmaeili, M. H., Bahari, B., & Salari, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.001 · Cited by 81 · see citing works

Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging

Krell‐Roesch, J., Lowe, V. J., Neureiter, J., Pink, A., Roberts, R. O., Mielke, M. M., Vemuri, P., Stokin, G. B., Christianson, T. J. H., Jack, C. R., et al. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217002368 · Cited by 81 · see citing works

Do Older Adults Need Sleep? A Review of Neuroimaging, Sleep, and Aging Studies

Scullin, M. K. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0086-z · Cited by 82 · see citing works

Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease

Pradeepkiran, J. A., Baig, J., Islam, M. A., Kshirsagar, S., & Reddy, P. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0286 · Cited by 81 · see citing works

Anxiety and risk of dementia: Systematic review and meta-analysis of prospective cohort studies

Santabárbara, J., Lipnicki, D. M., Villagrasa, B., Lobo, E., & López‐Antón, R. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.10.014 · Cited by 77 · see citing works

Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice

Zhang, H., Su, Y., Sun, Z., Chen, M., Han, Y., Li, Y., Dong, X., Ding, S., Fang, Z., Li, W., et al. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2021.03.003 · Cited by 76 · see citing works

Redox modulation of cellular stress response and lipoxin A4 expression by Coriolus versicolor in rat brain: Relevance to Alzheimer's disease pathogenesis

Salinaro, A. T., Siracusa, R., Paola, R. D., Scuto, M. C., Fronte, V., Koverech, G., Luca, M., Serra, A., Toscano, M. A., Petralia, A., et al. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.09.012 · Cited by 75 · see citing works

The association of anxiety, depression, and worry symptoms on cognitive performance in older adults

Vito, A. N. D., Calamia, M. R., Greening, S. G., & Roye, S. (2017) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2017.1416057 · Cited by 72 · see citing works

Aging faster: worry and rumination in late life are associated with greater brain age

Karim, H., Ly, M., Yu, G. Z., Krafty, R., Tudorascu, D., Aizenstein, H., & Andreescu, C. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.009 · Cited by 66 · see citing works

Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer’s Disease Pathology and Cognitive Decline

Johansson, M., Stomrud, E., Johansson, P., Svenningsson, A., Palmqvist, S., Janelidze, S., van Westen, D., Mattsson, N., & Hansson, O. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.01.012 · Cited by 69 · see citing works

Anxiety as a Risk Factor for Cognitive Decline: A 12-Year Follow-Up Cohort Study

Gulpers, B. J. A., Oude Voshaar, R. C., van Boxtel, M. P. J., Verhey, F. R. J., & Köhler, S. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.09.006 · Cited by 68 · see citing works

The impact of anxiety on the progression of mild cognitive impairment to dementia in Chinese and English data bases: a systematic review and meta‐analysis

Li, X., & Li, Z. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4694 · Cited by 69 · see citing works

Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study

Goukasian, N., Hwang, K. S., Romero, T., Grotts, J., Do, T. M., Groh, J. R., Bateman, D. R., & Apostolova, L. G. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031947 · Cited by 64 · see citing works

Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer’s Disease: A 6-Year Prospective Cohort Study

Pietrzak, R. H., Laws, S. M., Lim, Y. Y., Bender, S. J., Porter, T., Doecke, J. D., Ames, D. J., Fowler, C. J., Masters, C. L., Milicic, L., et al. (2016) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2016.08.006 · Cited by 63 · see citing works

A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress

Hoeijmakers, L., Lesuis, S. L., Krugers, H. J., Lucassen, P. J., & Kőrösi, A. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.02.003 · Cited by 63 · see citing works

NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease

Amani, M., Zolghadrnasab, M., & Salari, A. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.01.005 · Cited by 60 · see citing works

Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

Heurling, K., Leuzy, A., Zimmer, E. R., Lubberink, M., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3208-1 · Cited by 59 · see citing works

A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample: results from the MedDairy randomized controlled trial

Wade, A. T., Davis, C. R., Dyer, K. A., Hodgson, J. M., Woodman, R. J., Keage, H. A. D., & Murphy, K. J. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1543148 · Cited by 57 · see citing works

Anxiety adds the risk of cognitive progression and is associated with axon/synapse degeneration among cognitively unimpaired older adults

Sun, L., Li, W., Qiu, Q., Hu, Y., Yang, Z., & Xiao, S. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104703 · Cited by 55 · see citing works

Impact of Personality on Cognitive Aging: A Prospective Cohort Study

Caselli, R. J., Dueck, A. C., Locke, D. E. C., Henslin, B. R., Johnson, T. A., Woodruff, B. K., Hoffman‐Snyder, C., & Geda, Y. E. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000527 · Cited by 57 · see citing works

Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer’s disease

Yang, J., Kou, J., Lalonde, R., & Fukuchi, K.-I. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.05.012 · Cited by 55 · see citing works

Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time

Kuhn, E., Moulinet, I., Perrotin, A., La Joie, R., Landeau, B., Tomadesso, C., Bejanin, A., Sherif, S., De La Sayette, V., Desgranges, B., et al. (2019) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-019-0514-z · Cited by 51 · see citing works

Updating the evidence for an association between anxiety and risk of Alzheimer's disease: A meta-analysis of prospective cohort studies.

Santabárbara, J., Lipnicki, D. M., Bueno‐Notivol, J., Olaya, B., Villagrasa, B., & López‐Antón, R. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.065 · Cited by 54 · see citing works

Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State

Martorana, A., Lorenzo, F. D., Belli, L., Sancesario, G., Toniolo, S., Sallustio, F., Sancesario, G. M., & Koch, G. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12476 · Cited by 51 · see citing works

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder

Alhusaini, M., Eissa, N., Saad, A. K., Beiram, R., & Sadek, B. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.861094 · Cited by 49 · see citing works

Activity of Selected Group of Monoterpenes in Alzheimer’s Disease Symptoms in Experimental Model Studies—A Non-Systematic Review

Wojtunik‐Kulesza, K. A., Rudkowska, M., Kasprzak‐Drozd, K., Oniszczuk, A., & Borowicz, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147366 · Cited by 50 · see citing works

The impacts of a GO-game (Chinese chess) intervention on Alzheimer disease in a Northeast Chinese population

Lin, Q., Cao, Y., & Gao, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00163 · Cited by 47 · see citing works

Clinically relevant anxiety and risk of Alzheimer's disease in an elderly community sample: 4.5 years of follow-up.

Santabárbara, J., Villagrasa, B., López‐Antón, R., Olaya, B., Bueno‐Notivol, J., de la Cámara, C., Gracia‐García, P., Lobo, E., & Lobo, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.050 · Cited by 47 · see citing works

Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study

Kemppainen, N. M., Johansson, J. J., Teuho, J., Parkkola, R. K., Joutsa, J., Ngandu, T., Solomon, A., Stephen, R., Liu, Y., Hänninen, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004827 · Cited by 46 · see citing works

Temporal dynamics of cognitive performance and anxiety across older adulthood.

Petkus, A. J., Reynolds, C. A., Wetherell, J. L., Kremen, W. S., & Gatz, M. (2017) · Psychology and Aging · doi:10.1037/pag0000164 · Cited by 44 · see citing works

What’s That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease

Kelberman, M. A., Keilholz, S. D., & Weinshenker, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.583421 · Cited by 43 · see citing works

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment

Pink, A., Krell‐Roesch, J., Syrjanen, J. A., Vassilaki, M. E., Lowe, V. J., Vemuri, P., Stokin, G. B., Christianson, T. J. H., Kremers, W. K., Jack, C. R., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12504 · Cited by 45 · see citing works

Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment

Moon, B., Kim, S., Park, Y. H., Lim, J., Youn, Y. C., Kim, S., Jang, J., & Initiative, A. D. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170225 · Cited by 44 · see citing works

Insoluble Aβ overexpression in an App knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, affecting anxiety-related behaviours

Pervolaraki, E., Hall, S. P., Foresteire, D., Saito, T., Saido, T. C., Whittington, M. A., Lever, C., & Dachtler, J. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.040550 · Cited by 42 · see citing works

Stress and Alzheimer’s disease

Escher, C. M., Sannemann, L., & Jessen, F. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01988-z · Cited by 44 · see citing works

Neuroprotective effect of alpha‐pinene is mediated by suppression of the TNF‐α/NF‐κB pathway in Alzheimer's disease rat model

Khan‐Mohammadi‐Khorrami, M., Asle‐Rousta, M., Rahnema, M., & Amini, R. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23006 · Cited by 42 · see citing works

The SCD‐Well randomized controlled trial: Effects of a mindfulness‐based intervention versus health education on mental health in patients with subjective cognitive decline (SCD)

Marchant, N. L., Barnhofer, T., Klimecki, O. M., Poisnel, G., Lutz, A., Arenaza‐Urquijo, E., Collette, F., Wirth, M., Schild, A., Coll‐Padrós, N., et al. (2018) · Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions · doi:10.1016/j.trci.2018.10.010 · Cited by 38 · see citing works

Amyloid‐associated depression and ApoE4 allele: longitudinal follow‐up for the development of Alzheimer's disease

Qiu, W. Q., Zhu, H., Dean, M., Liu, Z., Vu, L., Fan, G., Li, H., Mwamburi, M., Steffens, D. C., & Au, R. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4339 · Cited by 41 · see citing works

Neuroprotective effect of emodin against Alzheimer's disease via Nrf2 signaling in U251 cells and APP/PS1 mice

Li, Z., Bi, H. C., Jiang, H., Song, J., Meng, Q., Zhang, Y., & Fei, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11747 · Cited by 40 · see citing works

Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer’s Disease

Kelberman, M. A., Anderson, C. R., Chlan, E., Rorabaugh, J. M., McCann, K. E., & Weinshenker, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215546 · Cited by 40 · see citing works

G protein–biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer’s disease mouse model

Huang, Y., Guimarães, T. R., Todd, N., Ferguson, C., Weiss, K. M., Stauffer, F., McDermott, B., Hurtle, B. T., Saito, T., Saido, T. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204828119 · Cited by 37 · see citing works

Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model

Pupyshev, A. B., Беличенко, В. М., Tenditnik, M. V., Bashirzade, A. A., Dubrovina, N. I., Ovsyukova, M. V., Akopyan, A. A., Fedoseeva, L. A., Короленко, Т. А., Amstislavskaya, T. G., et al. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173406 · Cited by 38 · see citing works

Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults

Jang, J. Y., Ho, J. K., Blanken, A. E., Dutt, S., Nation, D. A., & Initiative, T. A. D. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200190 · Cited by 36 · see citing works

Loss of SST and PV positive interneurons in the ventral hippocampus results in anxiety-like behavior in 5xFAD mice

Li, H., Zhao, J., Lai, L., Xia, Y., Wan, C., Wei, S., Liang, J., Chen, Y., & Xu, N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.05.013 · Cited by 34 · see citing works

Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer’s disease

Wu, K., Gao, X., Shi, B., Chen, S., Zhou, X., Li, Z., Gan, Y., Cui, L., Kang, J. X., Li, W., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.038 · Cited by 34 · see citing works

Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones

Wu, Y., Hang, Z., Tong, L., & Du, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03784-w · Cited by 34 · see citing works

Administering crocin ameliorates anxiety‐like behaviours and reduces the inflammatory response in amyloid‐beta induced neurotoxicity in rat

Hadipour, M., Bahari, Z., Afarinesh, M. R., Jangravi, Z., Shirvani, H., & Meftahi, G. H. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13494 · Cited by 33 · see citing works

Childhood Secondhand Smoke Exposure and Risk of Dementia, Alzheimer's Disease and Stroke in Adulthood: A Prospective Cohort Study

Zhou, S., & Wang, K. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.10 · Cited by 33 · see citing works

Association Between Psychological Distress and Incident Dementia in a Population-Based Cohort in Finland

Sulkava, S., Haukka, J. K., Sulkava, R. O., Laatikainen, T. K., & Paunio, T. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.47115 · Cited by 33 · see citing works

Moderating risk of Alzheimer's disease through the use of anxiolytic agents

Burke, S. L., O’Driscoll, J., Alcide, A., & Li, T. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4614 · Cited by 30 · see citing works

Lifetime affective problems and later-life cognitive state: Over 50 years of follow-up in a British birth cohort study

James, S., Davis, D. H. J., O’Hare, C., Sharma, N., John, A., Gaysina, D., Hardy, R., Kuh, D. J., & Richards, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.078 · Cited by 30 · see citing works

Anxiolytic impact of Apelin-13 in a rat model of Alzheimer's disease: Involvement of glucocorticoid receptor and FKBP5

Aminyavari, S., Zahmatkesh, M., Khodagholi, F., & Sanati, M. (2019) · Peptides · doi:10.1016/j.peptides.2019.170102 · Cited by 30 · see citing works

Natriuretic peptides in the central nervous system: Novel targets for cognitive impairment

Mahinrad, S., de Craen, A. J. M., Yaşar, S., van Heemst, D., & Sabayan, B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.022 · Cited by 30 · see citing works

Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer’s Disease

Strikwerda‐Brown, C., Ozlen, H., Binette, A. P., Chapleau, M., Marchant, N. L., Breitner, J. C. S., & Villeneuve, S. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.01.001 · Cited by 29 · see citing works

Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease

Dang, M., Chen, Q., Zhao, X. B., Chen, K., Li, X., Zhang, J., Lu, J., Ai, L., Chen, Y., & Zhang, Z. (2022) · Human Brain Mapping · doi:10.1002/hbm.26043 · Cited by 29 · see citing works

How Do Modifiable Risk Factors Affect Alzheimer’s Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?

Ourry, V., Binette, A. P., St‐Onge, F., Strikwerda‐Brown, C., Chagnot, A., Poirier, J., Breitner, J. C. S., Arenaza‐Urquijo, E. M., Rabin, J. S., Buckley, R. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.003 · Cited by 28 · see citing works

A Remote Intervention to Prevent or Delay Cognitive Impairment in Older Adults: Design, Recruitment, and Baseline Characteristics of the Virtual Cognitive Health (VC Health) Study

Bott, N. T., Kumar, S., Krebs, C., Glenn, J. M., Madero, E. N., & Juusola, J. L. (2018) · JMIR Research Protocols · doi:10.2196/11368 · Cited by 27 · see citing works

Disclosure of Amyloid Status for Risk of Alzheimer Disease to Cognitively Normal Research Participants With Subjective Cognitive Decline: A Longitudinal Study

Wake, T., Tabuchi, H., Funaki, K., Ito, D., Yamagata, B., Yoshizaki, T., Nakahara, T., Jinzaki, M., Yoshimasu, H., Tanahashi, I., et al. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520904551 · Cited by 28 · see citing works

The long-term consequences of repetitive head impacts: Chronic traumatic encephalopathy

Alosco, M. L., & Stern, R. A. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00018-2 · Cited by 27 · see citing works

Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Lauterbach, E. C. (2016) · Europe PMC (PubMed Central) · Cited by 27 · see citing works

Psychotherapeutic interventions in individuals at risk for Alzheimer’s dementia: a systematic review

Rostamzadeh, A., Kahlert, A., Kalthegener, F., & Jessen, F. (2022) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-021-00956-8 · Cited by 26 · see citing works

Sex hormones, vascular factors and cognition

Szoeke, C. E. I., Downie, S., Parker, A. F., & Phillips, S. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100927 · Cited by 26 · see citing works

Elucidating the association between depression, anxiety, and cognition in middle-aged adults: Application of dimensional and categorical approaches

Perin, S., Lai, J., Pase, M. P., Bransby, L., Buckley, R. F., Yassi, N., Pietrzak, R. H., Maruff, P. T., & Lim, Y. Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.007 · Cited by 27 · see citing works

Exercise interventions to reduce anxiety in mid-life and late-life anxiety disorders and subthreshold anxiety disorder: a systematic review

Chong, T. W. H., Kootar, S., Wilding, H., Berriman, S., Curran, E. M., Cox, K. L., Bahar‐Fuchs, A., Peters, R. K., Anstey, K. J., Bryant, C., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221104958 · Cited by 26 · see citing works

Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults

Lewis, C., Bernstein, O. M., Grill, J. D., Gillen, D. L., & Sultzer, D. L. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.13 · Cited by 25 · see citing works

Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10‐year follow‐up community study

Gracia‐García, P., Bueno‐Notivol, J., Lipnicki, D. M., de la Cámara, C., Lobo, A., & Santabárbara, J. (2023) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1934 · Cited by 26 · see citing works

TFEB agonist clomiphene citrate activates the autophagy-lysosomal pathway and ameliorates Alzheimer's disease symptoms in mice

Lin, J. E., Yuan, Y., Huang, C., Zi, J., Li, L., Liu, J., Wu, X., Li, W., Zhao, Q. H., Li, Y., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107929 · Cited by 22 · see citing works

Effects of Mindfulness-based Interventions on Dementia Patients: A Meta-analysis

Wang, F. L., Tang, Q. Y., Zhang, L. L., Yang, J., Li, Y., Peng, H., & Wang, S. H. (2020) · Western Journal of Nursing Research · doi:10.1177/0193945920916750 · Cited by 22 · see citing works

Examining the Bidirectional Nature of Loneliness and Anxiety Among Older Adults in Daily Life

Bogart, K. V., Scott, S., Harrington, K., Felt, J. M., Sliwinski, M. J., & Graham‐Engeland, J. E. (2023) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbad105 · Cited by 22 · see citing works

Clinical and striatal dopamine transporter predictors of β-amyloid in dementia with Lewy bodies

Yoo, H. S., Lee, S., Chung, S. J., Lee, Y. H., Ye, B. S., Sohn, Y. H., Yun, M., & Lee, P. H. (2020) · Neurology · doi:10.1212/wnl.0000000000009168 · Cited by 22 · see citing works

Apathy and anxiety are early markers of Alzheimer's disease.

Johansson, M., Stomrud, E., Lindberg, O., Westman, E., Johansson, P., van Westen, D., Mattsson, N., & Hansson, O. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.008 · Cited by 156 · see citing works

The Relationship Between Amyloid Burden, Cognition and Neuropsychiatric Symptoms in Individuals with Amnestic Cognitive Decline

Alokley, A. A., Vargas‐González, J., Alotibi, H. A., Dimal, N. P. M., Ingelsson, M., Tang‐Wai, D. F., & Tartaglia, M. C. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70857_102118

Cognitive change by anxiety and depressive symptoms in subjective cognitive decline: An implication to prevent Alzheimer's disease

Ahn, S. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.053197

Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults

Lewis, C., Bernstein, O. M., Grill, J. D., Gillen, D. L., & Sultzer, D. L. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.13 · Cited by 25 · see citing works

IC‐P‐139: LONGITUDINAL DEPRESSIVE SYMPTOMS AND CORTICAL AMYLOID ARE ASSOCIATED WITH COGNITIVE DECLINE IN OLDER ADULTS

Gatchel, J. R., Rabin, J. S., Buckley, R. F., Locascio, J. J., Quiroz, Y. T., Vannini, P., Amariglio, R. E., Rentz, D. M., Blacker, D., Johnson, K. A., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2205